Active sites in complement component C3 mapped by mutations at indels

Journal of Immunology

Volumn 161, Issue 9, 1998, Pages 4785-4794

  Ogata, Ronald T ^a,b   Ai, Rong ^a   Low, Pamela J ^a  

^a University of California San Diego Medical Biology Institute   (United States)

^b TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COBROTOXIN; COMPLEMENT COMPONENT C3; COMPLEMENTARY DNA; MONOCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MUTATION; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; COMPLEMENT C3; COMPLEMENT C3-C5 CONVERTASES; COS CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMOLYSIS; HUMANS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; MUTAGENESIS, INSERTIONAL; MUTAGENESIS, SITE-DIRECTED; POLYMORPHISM, GENETIC; PROTEIN BINDING; PROTEIN CONFORMATION; RECOMBINANT FUSION PROTEINS; SEQUENCE DELETION; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 0032212249     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Law, S. K. A., and K. B. M. Reid. 1995. Complement, 2nd Ed. IRL Press, Oxford, U.K.
2. Fishelson, Z. 1991. Complement C3: a molecular mosaic of binding sites. Mol. Immunol. 28:545.
3. Taniguchi-Sidle, A., and D. E. Isenman. 1992. Mutagenesis of the Arg-Gly-Asp triplet in human complement component C3 does not abolish binding of iC3b to the leukocyte integrin complement receptor type III (CR3, CD11b/CD18). J. Immunol. 267:635.
4. Taniguchi-Sidle, A., and D. E. Isenman. 1994. Interactions of human complement component C3 with factor B and with complement receptor type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) involve an acidic sequence at the N-terminus of the C3 α′-chain. J. Immunol. 153:5285.
5. Diefenbach, R. J., and D. E. Isenman. 1995. Mutation of residues in the C3dg region of human complement component C3 corresponding to a proposed binding site for complement receptor type 2 (CR2, CD21) does not abolish binding of iC3b or C3dg to CR2. J. Immunol. 154:2303.
6. Lambris, J. D., Z. Lao, T. J. Oglesby, J. P. Atkinson, C. E. Hack, and J. D. Becherer. 1996. Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component. J. Immunol. 156:4821.
7. Mathias, P., C. J. Carrillo, N. E. Zepf, N. R. Cooper, and R. T. Ogata. 1992. Mutants of complement component C3 cleaved by the C4-specific C1s protease. Proc. Natl. Acad. Sci. USA 89:8125.
8. Ogata, R. T., and P. J. Low. 1995. Complement component C5: engineering of a mutant that is specifically cleaved by the C4-specific C1s protease. J. Immunol. 155:2642.
9. Ogata, R. T., and P. J. Low. 1997. Complement-inhibiting peptides identified by proximity to indels in the C3/4/5 protein family. J. Immunol. 158:3852.
10. Kruskal, J. B. 1983. An overview of sequence comparison. In Time Warps, String Edits, and Macromolecules: Theory and Practice of Sequence Comparison. D. Sankoff and J. B. Kruskal, eds. Addison-Wesley, Reading, MA, p. 1.
11. Freimuth, P. I., J. W. Taylor, and E. T. Kaiser. 1990. Introduction of guest peptides into Escherichia coli alkaline phosphatase. J. Biol. Chem. 265:896.
12. Pascarella, S., and P. Argos. 1992. Analysis of insertions/deletions in protein structures. J. Mol. Biol. 224:461.
13. Betton, J.-M., P. Martineau, W. Saurin, and M. Hofnung. 1993. Location of tolerated insertions/deletions in the structure of the maltose binding protein. FEBS Lett. 325:34.
14. Sibanda, B. L., and J. M. Thornton. 1993. Accomodating sequence changes in β-hairpins in proteins. J. Mol. Biol. 229:428.
15. Rizo, J., and L. M. Gierasch. 1992. Constrained peptides: models of bioactive peptides and protein substructures. Annu. Rev. Biochem. 61:387.
16. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51.
17. Ogata, R. T., N. R. Cooper, B. M. Bradt, P. Mathias, and M. Picchi. 1989. Murine complement component C4 and sex-limited protein: identification of amino acid residues essential for C4 function. Proc. Natl. Acad. Sci. USA 86:5575.
18. Ogata, R. T., P. J. Low, and M. Kawakami. 1995. Substrate specificities of the protease of mouse serum Ra-reactive factor. J. Immunol. 154:2351.
19. Miyama, A., T. Kato, S. Horai, J. Yokoo, and S. Kashiba. 1975. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. I. Generation of the activated complex. Biken J. 18:193.
20. von Zabern, I., B. Hinsch, H. Przyklenk, G. Schmidt, and W. Vogt. 1980. Comparison of Naja n. naja and Naja h. haje cobra venom factors: correlation between binding affinity for the fifth component of complement and mediation of its cleavage. Immunobiology 157:499.
21. Monod, J., J. Wyman, and J.-P. Changeux. 1965. On the nature of allosteric transitions. J. Mol. Biol. 12:88.
22. Law, S. K. A., and A. W. Dodds. 1997. The internal thioester and the covalent binding properties of the complement proteins C3 and C4. Protein Sci. 6:263.
23. Müller-Eberhard, H. J. 1988. Molecular organization and function of the complement system. Annu. Rev. Biochem. 57:321.
24. Pangburn, M. K., R. D. Schreiber, and H. J. Müller-Eberhard. 1981. formation of the initial C3 convertase of the alternative complement pathway: acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3. J. Exp. Med. 154:856.
25. Sim, R. B., and E. Sim. 1981. Autolytic fragments of complement components C3 and C4 under denaturing conditions, a property shared with α2-macroglobulin. Biochem. J. 193:129.
26. Davis, A. E., R. A. Harrison, and P. J. Lachmann. 1984. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (α2D), and C3g. J. Immunol. 132:1960.
27. DeBruijn, M. H. L., and G. H. Fey. 1985. Human complement component C3: cDNA coding sequence and derived primary structure. Proc. Natl. Acad. Sci. USA 82:708.
28. Alsenz, J., D. Avila, H. P. Huemer, I. Esparza, J. D. Becherer, T. Kinoshita, Y. Wang, S. Oppermann, and J. D. Lambris. 1992. Phylogeny of the third component of complement, C3: analysis of the conservation of human CR1, CR2, H, and B binding sites, concanavalin A binding sites, and thiolester bond in the C3 from different species. Dev. Comp. Immunol. 16:63.
29. Lambris, J. D., Z. Lao, J. Pang, and J. Alsenz. 1993. Third component of trout complement. cDNA cloning and conservation of functional sites. J. Immunol. 151:6123.
30. Ebanks, R. O., A. S. I. Jaikaran, M. C. Carroll, M. J. Anderson, R. D. Campbell, and D. E. Isenman. 1992. A single arginine to tryptophan interchange at β-chain residue 458 of human complement component C4 accounts for the defect in classical pathway C5 convertase activity of allotype C4A6. J. Immunol. 148:2803.
31. Ebanks, R. O., and D. E. Isenman. 1995. Evidence for the involvement of arginine 462 and the flanking sequence of human C4 β-chain in mediating C5 binding to the C4b subcomponent of the classical complement pathway C5 convertase. J. Immunol. 154:2808.
32. Kim, Y. U., M. C. Carroll, D. E. Isenman, M. Nonaka, P. Pramoonjago, J. Takeda, K. Inoue, and T. Kinoshita. 1992. Covalent binding of C3b to C4b within the classical complement pathway C5 convertases: determination of amino acid residues involved in ester linkage formation. J. Biol. Chem. 267:4171.
33. Kinoshita, T., Y. Takata, H. Kozono, J. Takeda, K. Hong, and K. Inoue. 1988. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme. J. Immunol. 141:3895.
34. Belt, K. T., M. C. Carroll, and R. R. Porter. 1984. The structural basis of multiple forms of human complement component C4. Cell 36:907.
35. Hortin, G., A. C. Chan, K. F. Fok, A. W. Strauss, and J. P. Atkinson. 1986. Sequence analysis of the COOH terminus of the α-chain of the fourth component of human complement: identification of the site of its extracellular cleavage. J. Biol. Chem. 261:9065.